Skip to Content

MYLAN 5150 MYLAN 5150 (Nizatidine 150 mg)

Pill with imprint MYLAN 5150 MYLAN 5150 is Purple, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Mylan Pharmaceuticals Inc..

Nizatidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; indigestion and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 5150 MYLAN 5150

Nizatidine 150 mg MYLAN 5150 MYLAN 5150
Nizatidine 150 mg MYLAN 5150 MYLAN 5150 Front
Nizatidine 150 mg MYLAN 5150 MYLAN 5150 Back
Nizatidine 150 mg MYLAN 5150 MYLAN 5150
Nizatidine 150 mg MYLAN 5150 MYLAN 5150

Nizatidine

Imprint
MYLAN 5150 MYLAN 5150
Strength
150 mg
Color
Purple
Size
15.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5150
Inactive Ingredients
ammonia, lactose anhydrous, silicon dioxide, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin, isopropyl alcohol, magnesium stearate, butyl alcohol, corn starch, propylene glycol, shellac, dimethicone, sodium lauryl sulfate, titanium dioxide, FD&C Red No. 3

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.